Lifting the Burden of Cardiovascular Disease and Diabetes

Watch the above introductory video to review the curriculum

Welcome to the ACC course CVD and DM: Lifting the Burden of Cardiovascular Disease and Diabetes.

In this course, you will review the interplay of current and emerging diabetes mellitus and cardiovascular disease therapies and how those therapies impact patient outcomes. You will be given the opportunity to discuss therapy application, pros and cons with your colleagues, as well as practice educating the patient about therapy and lifestyle change options in relation to CVD and DM.

To learn more about how to use this course, please watch the introductory video and/or download a one-page instructional pdf.


Click on a topic below to begin:

icon

Patient Interactive: A Conversation With an Acute Patient
(0.50 CME/CNE/MOC credits)

icon

Patient Interactive: A Conversation With a Chronic Patient
(0.50 CME/CNE/MOC credits)


Faculty

Mikhail Kosiborod, MD, FACC (Co-chair)
Professor
St. Luke’s Mid America Heart Institute
Kansas City, MO

Michael Blaha, MD, MPH (Co-chair)
Assistant Professor and Director of Clinical Research
Johns Hopkins School of Medicine
Baltimore, MD

Silvio Inzucchi, MD
Professor of Medicine
Yale University School of Medicine
New Haven, CT

Michael Nassif, MD
St. Luke’s Mid America Heart Instiute
Kansas City, MO

Melissa Magwire, RN, CDE
Shawnee Mission Health
Shawnee, KS

Target Audience

This activity is primarily intended for general adult cardiologists and the cardiovascular care team (nurse practitioners, registered nurses, physician assistants, and pharmacists). Endocrinologists and primary care physicians may also benefit from this education.

Learning Objectives

Upon completion of one or more activities proposed, learners should be able to:

    1. Compare the disproportionate CV morbidity and mortality risks in patients with diabetes vs patients without T2DM.
    2. Differentiate various T2DM pharmaceutical therapies with respect to cardiovascular outcomes.
    3. Analyze current and emerging evidence from clinical trials focused on the management of high-risk patients with CV-related comorbidities.
    4. Evaluate effective treatment options for patients with T2DM and CV disease spanning lifestyle modifications, prevention strategies for dyslipidemia, smoking, obesity, hypertension, and pharmaceutical management for glucose control.

 

Each activity offers the credit amounts listed above. After completing the evaluation for each activity, the option to claim CME/CNE/MOC will appear. A Certificate of Participation is also available.

Learners will be guided through three stages of learning (review, innovate, and lead), detailed below.

Review

Learners will be introduced to material through expert perspective and expert dialogue videos and will be given the opportunity to discuss in moderated format, as well as on their own, topics related to the material.  Learners will also be given access to faculty via virtual office hours, and will be given the opportunity to ask questions pertaining to the covered topics or current and related treatment issues they are facing.

Innovate 

Learners will be introduced to material through a variety of podcasts and will be given the opportunity to apply new knowledge through case-studies and branching scenarios, as well as discuss emerging and new clinical trial data and treatment options with peers and experts in a moderated discussion topic forum. 

Lead 

Learners will be asked to demonstrate an understanding of patient education tactics in relation to diabetes mellitus and cardiovascular disease treatment as well as will be charged with patient lifestyle change advocacy.

Learners will be introduced to material through expert perspective videos and will be given the opportunity to apply new knowledge through participation in interactive case-based scenarios videos.

Please clear your browser history and try logging in again. If you are still having trouble, please contact the Resource Center by calling (800) 253-4636, ext. 5603 or (202) 375-6000, ext. 5603 or email us at resource@acc.org.

You do have to log in to be able to access this content. If you do not have an account, please create one here:

Create an account

If you create an account, please make sure to log in before viewing this course.

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC. and Novo Nordisk Inc.